A common 93-kb duplicated DNA sequence at 1q21.2 in acute lymphoblastic leukemia and Burkitt lymphoma.

In three patients with acute lymphoblastic leukemia (ALL) and in another with Burkitt lymphoma (BL), conventional cytogenetics and fluorescence in situ hybridization (FISH), applied singly or in combination, showed 1q duplication in two cases of ALL with hyperdiploid karyotypes, 1q duplication resulting from an unbalanced translocation in a third case of ALL, and inv dup(1)(q) in a patient with BL. Centromeric or telomeric breakpoints and extension of the 1q duplicons varied in each case. FISH defined a minimal, common duplicated region of 93kb at band 1q21.2 corresponding to clone RP11-212K13. In this region three putative oncogenes or tumor suppressor genes have been mapped: SF3B4 (splicing factor 3b, subunit 4), OTUD7B (OTU domain containing 7B), and MTMR11 (myotubularin related protein 11). For the first time, a minimal common 1q21.2 duplicated sequence has been identified in lymphoid malignancies in a region where putative oncogenes or suppressor genes have been mapped. This finding elucidates the genomic background of ALL and BL with 1q duplication and provides the basis for molecular studies investigating which genes are involved in leukemogenesis or disease progression in these cases.

[1]  Aldo Quattrone,et al.  Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2 , 2000, Nature Genetics.

[2]  R. Berger,et al.  Cytogenetic studies on Burkitt's lymphoma-leukemia. , 1982, Cancer genetics and cytogenetics.

[3]  Michael Karin,et al.  NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.

[4]  Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations. , 1991 .

[5]  P. Campbell,et al.  The myeloproliferative disorders. , 2006, The New England journal of medicine.

[6]  A. Aventín,et al.  Regions of juxtaposition in unbalanced 1q rearrangements of malignant hemopathies , 2001, Leukemia.

[7]  T. Blundell,et al.  A Novel Type of Deubiquitinating Enzyme* , 2003, Journal of Biological Chemistry.

[8]  S. Lee,et al.  Role of 1q trisomy in tumorigenicity, growth, and metastasis of human leukemic B-cell clones in nude mice. , 1990, Cancer research.

[9]  C. Mecucci,et al.  Successful use of the same slide for consecutive fluorescence in situ hybridization experiments , 1996, Genes, chromosomes & cancer.

[10]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .

[11]  S. Klauck,et al.  A gene mutated in X–linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast , 1996, Nature Genetics.

[12]  T. T. Lau,et al.  Hereditary duplication of proximal chromosome 1q (q11q22) in a patient with T lymphoblastic lymphoma/leukaemia: a family study using G banding and comparative genomic hybridisation , 2002, Journal of medical genetics.

[13]  Yongsheng Huang,et al.  Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation. , 2006, Blood.

[14]  D. Ledbetter,et al.  An optimized set of human telomere clones for studying telomere integrity and architecture. , 2000, American journal of human genetics.

[15]  R. Ravazzolo,et al.  Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. , 2003, American journal of human genetics.

[16]  R. Berger,et al.  Fluorescence in situ hybridization analysis of chromosome 1 abnormalities in hematopoietic disorders: rearrangements of DNA satellite II and new recurrent translocations , 1999, Leukemia.

[17]  J. Dixon,et al.  PTEN and myotubularin phosphoinositide phosphatases: bringing bioinformatics to the lab bench. , 2001, Current opinion in cell biology.